Source: Pharmacy Times
Expanding the pharmacist’s role in diabetes care can lead to improved outcomes for patients by using shared decision-making and presenting information in a way that helps patients understand the risks and benefits of various choices.
Canadian pharmacists involved in a publicly-funded initiative that reimburses them for medication review and diabetes education for patients who have type 1 or type 2 diabetes have published an article that describes incorporating a decision aid for patients into their medication review and diabetes education. This initiative uses a decision-making tool developed by the Mayo Clinic in Rochester, Minnesota.
Leave a Reply